Saturday, May 10, 2025

Yearly Archives: 2020

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination with azacitidine, or...

Pharmacovigilance Interview Questions 2020

We have written this blog especially for freshers after consulting many job aspirant who has experienced interviews in PV recently (in 2019-20). Also read:Clinical...

CHMP recommends approval of Dupixent® for children with severe atopic dermatitis

October 16, 2020 – "The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent® (dupilumab), recommending to...

Novartis receives positive CHMP opinion for Leqvio® for the treatment of high cholesterol

October 16, 2020:"Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted a positive opinion and recommended granting...

Roche signs deal with Dyno Therapeutics for gene therapy vectors

October 14, 2020: "Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy, announced a collaboration and license agreement with Roche to...

NIHR publishes dynamic themed review into ‘ongoing COVID’

October 15, 2020: "The National Institute for Health Research Centre for Engagement and Dissemination has today published its first dynamic themed review of the scientific evidence...

Interview with Kashish Gupta: NIPER 2020, AIR-36

NIPER is a well renowned institute that offers Master's degree after qualifying GPAT (Graduate Pharmacy Aptitude Test) and NIPER entrance test. NIPER offers masters...

RPS calls for action to fight counterfeit medicines

October 13, 2020: The Royal Pharmaceutical Society of Great Britain (RPS) has called on the UK government to take immediate action to fight counterfeit...

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study

October 06, 2020: "Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial...

UK inks deal with Abingdon Health for rapid COVID-19 antibody tests

October 7, 2020: "The UK authorities has introduced a deal with Abingdon Health for the provision of the corporate’s AbC-19 rapid COVID-19 antibody tests. The...

BMS Opdivo plus Yervoy misses the mark in high-risk melanoma Patients

October 02, 2020: "Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for patients who...

COVID-19 disrupting mental health services in most countries, WHO survey

October 05, 2020: The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental...
- Advertisment -

Most Read